Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study

NCT03707574 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03707574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
July 16, 2019
Completion date
January 23, 2026
Enrollment
64 (actual)
Sites
144

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant neoplasm, advanced melanoma, advanced renal cell carcinoma, anatomic stage iii breast cancer ajcc v8, anatomic stage iiia breast cancer ajcc v8, anatomic stage iiib breast cancer ajcc v8, anatomic stage iiic breast cancer ajcc v8, anatomic stage iv breast cancer ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8, clinical stage ivb gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iii gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iiia gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iiib gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iv gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage ivb gastroesophageal junction adenocarcinoma ajcc v8, prognostic stage iii breast cancer ajcc v8, prognostic stage iiia breast cancer ajcc v8, prognostic stage iiib breast cancer ajcc v8, prognostic stage iiic breast cancer ajcc v8, prognostic stage iv breast cancer ajcc v8, stage iii colorectal cancer ajcc v8, stage iii lung cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iiia colorectal cancer ajcc v8, stage iiia lung cancer ajcc v8, stage iiia ovarian cancer ajcc v8, stage iiia prostate cancer ajcc v8, stage iiia1 ovarian cancer ajcc v8, stage iiia2 ovarian cancer ajcc v8, stage iiib colorectal cancer ajcc v8, stage iiib lung cancer ajcc v8, stage iiib ovarian cancer ajcc v8, stage iiib prostate cancer ajcc v8, stage iiic colorectal cancer ajcc v8, stage iiic lung cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic prostate cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv lung cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv prostate cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage iva lung cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva prostate cancer ajcc v8, stage ivb colorectal cancer ajcc v8, stage ivb lung cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb prostate cancer ajcc v8, stage ivc colorectal cancer ajcc v8